Compare QSI & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QSI | LFCR |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | 145 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 190.9M |
| IPO Year | N/A | 1996 |
| Metric | QSI | LFCR |
|---|---|---|
| Price | $0.76 | $4.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $1.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 2.7M | 133.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $618.07 | $5.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $0.69 | $3.63 |
| 52 Week High | $3.10 | $8.98 |
| Indicator | QSI | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 41.79 | 37.81 |
| Support Level | $0.69 | $4.22 |
| Resistance Level | $1.11 | $5.27 |
| Average True Range (ATR) | 0.04 | 0.23 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 45.31 | 22.16 |
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.